Stocks and Investing
Stocks and Investing
Thu, February 13, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Amit Hazan Initiated (ABT) at Hold and Held Target at $96 on, Feb 13th, 2020
Amit Hazan of Goldman Sachs, Initiated "Abbott Laboratories" (ABT) at Hold and Held Target at $96 on, Feb 13th, 2020.
Amit has made no other calls on ABT in the last 4 months.
There are 9 other peers that have a rating on ABT. Out of the 9 peers that are also analyzing ABT, 3 agree with Amit's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Marie Thibault of "BTIG" Initiated at Hold on, Thursday, February 6th, 2020
- Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $102 on, Thursday, January 23rd, 2020
- Christopher Pasquale of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, January 2nd, 2020
These are the ratings of the 6 analyists that currently disagree with Amit
- Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $105 on, Thursday, January 23rd, 2020
- Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $104 on, Thursday, January 23rd, 2020
- Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $99 on, Thursday, January 23rd, 2020
- Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $103 on, Thursday, January 23rd, 2020
- David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $101 on, Tuesday, December 17th, 2019
- Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $98 on, Thursday, October 17th, 2019